- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00425139
Evaluation of a Video Game for Adolescents and Young Adults With Cancer
Multi-site Evaluation of a Video Game for Adolescents and Young Adults With Cancer
Studieoversikt
Detaljert beskrivelse
POPULATION: Approximately 340 patients will be enrolled in this study. Patients will be 13 to 29 years of age with any cancer (original diagnosis or relapse), currently receiving treatment and expected to be on treatment for at least 4 - 6 months following Baseline assessment, and able to communicate effectively in English, Spanish, or French. Approximately 170 patients will be enrolled in each of the two treatment groups. Each group will receive either the "Re-Mission" video game and a popular interactive video game, or just the popular interactive video game.
DESIGN: This is a multi-center, randomized trial, with patients randomized to one of two groups. One group (50% of patients) will receive the active intervention, which is the psycho-educational video game module called Re-Mission and a popular video game (hereafter "RE-MISSION") and another group (50 % of patients) will be in a game control group and receive a popular video game only (hereafter "GAME CONTROL. The games in the RE-MISSION and GAME CONTROL groups are delivered on identical mini, personal computers (hereafter "Mini-PC").
INTERVENTION: Each patient in the RE-MISSION group will be asked to play "Re-Mission" along with the popular video game for at least one hour a week for a period of ten to fourteen weeks. "Re-Mission" presents a 3-D environment in which the player can manipulate a humanoid character inside the virtual body of a patient with cancer. Game-play consists of guiding the character to destroy cancer cells and other "enemies" in the body (e.g., bacteria) while avoiding injury or weakness. During the process of playing the game and guiding the character through a series of missions, the player learns about chemotherapy and other medical treatments, health-promoting self-care behaviors, infections, and pain management. In addition, the game has also been designed to facilitate the patient's ability to share knowledge and concerns with others.
DURATION OF STUDY: 9 -12 months
Studietype
Registrering
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Victoria
-
Parkville, Victoria, Australia, 03052
- Royal Children's Hospital
-
-
-
-
Alberta
-
Calgary, Alberta, Canada, T2T 5C7
- Calgary Alberta Children's Hospital
-
-
Ontario
-
Hamilton, Ontario, Canada, L8N 3Z5
- McMaster University
-
Ottawa, Ontario, Canada, K1H 8LI
- Children's Hospital of Eastern Ontario
-
-
Quebec
-
Montreal, Quebec, Canada, H3H 1P3
- McGill Univ Health Ctr - Montreal Children's Hospital
-
Montreal, Quebec, Canada, H3T 1C5
- Hôpital Ste-Justine
-
Ste-Foy, Quebec, Canada, G1V 4G2
- Centre Hospitalier Universitaire de Quebec
-
-
-
-
California
-
Duarte, California, Forente stater, 91010
- City of Hope National Medical Center
-
Los Angeles, California, Forente stater, 90027
- Los Angeles Children's Center for Cancer and Blood Disease
-
Orange, California, Forente stater, 92868
- Children's Hospital of Orange County
-
Palo Alto, California, Forente stater, 94304
- Lucile Packard Children's Hospital at Stanford
-
-
Florida
-
Fort Myers, Florida, Forente stater, 33908
- Children's Hospital of SW Florida / Lee Memorial Health System
-
Jacksonville, Florida, Forente stater, 32207
- Nemours Children's Clinic-Jacksonville
-
St. Petersburg, Florida, Forente stater, 33701
- All Children's Hospital
-
Tampa, Florida, Forente stater, 33607
- St. Joseph's Children's Hospital of Tampa
-
-
Hawaii
-
Honolulu, Hawaii, Forente stater, 96826
- Kapiolani Medical Center
-
-
Louisiana
-
New Orleans, Louisiana, Forente stater, 70118
- LSU Children's Hospital of New Orleans
-
-
Massachusetts
-
Boston, Massachusetts, Forente stater, 02115
- Dana-Farber Cancer Institute and Children's Hospital
-
-
Michigan
-
Grand Rapids, Michigan, Forente stater, 49503
- DeVos Children's Hospital
-
Grosse Pointe Woods, Michigan, Forente stater, 48236
- St John Van Elslander Cancer Center
-
-
Minnesota
-
St. Paul, Minnesota, Forente stater, 55404
- Children's Health Care - Minneapolis
-
-
Missouri
-
Kansas City, Missouri, Forente stater, 64108
- Children's Mercy Hospital
-
St. Louis, Missouri, Forente stater, 63110
- Washington University
-
-
New Mexico
-
Albuquerque, New Mexico, Forente stater, 87131-0001
- Children's Hospital of New Mexico
-
-
New York
-
Rochester, New York, Forente stater, 14642
- Golisano Children's Hospital, University of Rochester
-
-
Oklahoma
-
Tulsa, Oklahoma, Forente stater, 74136
- Warren Clinic / Saint Francis Hospital
-
-
Oregon
-
Portland, Oregon, Forente stater, 97227
- Legacy Emanuel Children's Cancer Program
-
Portland, Oregon, Forente stater, 97239
- Doernbecher Childrens Hospital - OHSU
-
-
Texas
-
Austin, Texas, Forente stater, 78701-1096
- Children's Hospital of Austin
-
Corpus Christi, Texas, Forente stater, 78411
- Driscoll Children's Hospital
-
Fort Worth, Texas, Forente stater, 76104
- Cook Children's Medical Center
-
San Antonio, Texas, Forente stater, 78207
- Christus Santa Rosa Children's Hospital
-
-
Virginia
-
Norfolk, Virginia, Forente stater, 23507
- Children's Hospital of The King's Daughters
-
-
Washington
-
Spokane, Washington, Forente stater, 99204
- Deaconess Medical Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Male or female patient 13 to 29 years of age with a cancer diagnosis.
- Patient who is currently receiving treatment and is expected to remain on treatment for at least 4 - 6 months.
Exclusion Criteria:
- Patient who has a history of seizures due to photosensitivity.
- Patient who has been determined by the investigator to be incapable of following the study schedule or study directions for any reason.
- Patient who can not communicate effectively with study personnel in English, Spanish, or French.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Hva måler studien?
Primære resultatmål
Resultatmål |
|---|
|
Livskvalitet
|
|
Binding
|
|
Følelse av mestringsevne
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Pamela M Kato, HopeLab Foundation
Publikasjoner og nyttige lenker
Generelle publikasjoner
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- HL-04-001
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .